Emerging biomarkers of immune checkpoint inhibitor toxicity in triple-negative breast cancer: a mini-review
Immune checkpoint inhibitors (ICI) have revolutionized the treatment of TNBC, leading to durable responses and improved survival. With the adoption of immunotherapy into high-risk early-stage and selected metastatic triple-negative breast cancer (TNBC)…